Pharmaceutical research is one of the most advanced and heavily regulated sectors in the UK economy. From developing life-saving medicines to improving manufacturing methods and delivering innovative drug delivery systems, UK pharmaceutical companies are at the forefront of scientific progress.
However, drug development and pharmaceutical research are time-consuming, costly, and filled with scientific uncertainty. Every new treatment must go through rigorous testing to prove its safety, effectiveness, and compliance with UK regulatory bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA).
R&D tax relief is designed to support UK companies that face these scientific and technological challenges. To qualify, your business must be working to achieve a scientific advancement and must be overcoming scientific uncertainty—situations where the outcome is unknown and requires experimentation, research, and testing to resolve.
Here are some typical examples of qualifying activities in the UK pharmaceutical sector:
Developing New Medicines or Therapies
Researching and developing new chemical compounds, biological treatments, or combination therapies that target specific conditions or diseases. This includes pre-clinical studies and clinical trial preparations, even when the research is unsuccessful or the outcome is uncertain.
Improving Drug Formulation and Delivery Methods
Working on new drug delivery technologies — such as inhalers, patches, or slow-release capsules — to improve patient outcomes or make existing medicines more effective or easier to administer.
Solving Manufacturing Process Challenges
Developing new manufacturing methods that improve yield, reduce waste, or meet Good Manufacturing Practice (GMP) requirements, especially when scaling up from laboratory to production scale.
Meeting Changing Regulatory Requirements
Engineering new processes or reformulating products to comply with updated UK regulations, such as MHRA standards or UKCA marking, when this requires overcoming scientific or technical barriers.
Enhancing Stability and Shelf Life
Researching and developing improved formulations or packaging solutions that extend the shelf life of pharmaceutical products without compromising safety or effectiveness.
Investigating New Uses for Existing Medicines
Conducting research into additional therapeutic applications for existing drugs, including repurposing treatments for new conditions, which often requires additional scientific validation.
Developing New Testing or Diagnostic Methods
Creating new diagnostic technologies, laboratory processes, or testing methods that help identify patient needs or optimise treatment pathways in the UK healthcare system.
If your pharmaceutical business is tackling these kinds of challenges here in the UK, you may be eligible to claim R&D tax relief. This can provide valuable financial support, helping you continue investing in research that improves healthcare outcomes for patients nationwide.